Over the last three decades, clinical observations, studies and research have established that thalassaemia major is a treatable condition.

The major components of treatment are Blood transfusion therapy and Iron Overload & iron chelation.

Due to the excess iron in body organs, many complications may arise involving mainly the Heart, Endocrine system and Liver.

In addition, transfusion dependent patients, such as those with β-thalassaemia major are prone also to transfusion-associated infections.

Read TIF’s Position Paper on the Chronic Hepatitis C in Transfusion Dependent Thalassaemia.

Management of other forms of thalassaemias & Abnormal haemoglobins can be found here.